|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Merrimack Pharmaceuticals, Inc.
| | | Phone: | (617) 441-1000 | Fax: | (617) 491-1386 | Year Established: | 2000 | Ticker: | MACK | Exchange: | NASDAQ | Main Contact: | Clet Niyikiza, Ph.D., Executive VP, Development | | Other Contacts: | Jean M. Franchi, CFO Thomas E. Needham, Jr., M.B.A., CBO Richard Peters, M.D., Ph.D., President & CEO Sergio L. Santillana, M.D., MSc, CMO Edward J. Stewart, Senior VP & President, Merrimack Healthcare Solutions Daryl Drummond, Ph.D., Head of Research Fazal R. Khan, Ph.D., Senior VP, Manufacturing William M. McClements, Senior VP, Corporate Operations Ulrik B. Nielsen, Ph.D., Senior VP & CSO Vincent F. Simmon, Ph.D., COO
| | Company Description | Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development. | |
|
|
|
|
|